CEACAM5, also known as CD66e, is a glycoprotein from the carcinoembryonic antigen (CEA) family, playing a crucial role in cell adhesion and cancer progression. It is widely studied in oncology research, particularly in colorectal, gastric, and lung cancers. Scientists investigate the protein to develop targeted therapies, diagnostic tools, and immunotherapies.
CEACAM5 is primarily expressed on the surface of epithelial cells and is involved in intercellular adhesion. Its overexpression is commonly associated with tumor progression and metastasis, making it a valuable biomarker in oncology. Due to its role in cancer, CD66e has been extensively studied as a potential target for monoclonal antibody therapies and other precision medicine approaches.
CEACAM5 (CD66e) Peptide Tools for Research:
We offer high-quality CEACAM5 (CD66e) peptides designed to support cancer research and immunological studies. Our peptides are synthesized with precision to ensure high purity and reliability in experimental applications.
Featured CEACAM5 Peptides:
Applications of CEACAM5 Peptides in Research
Cancer Immunotherapy: CEACAM5/CD66e is a target for monoclonal antibodies and CAR-T cell therapy development.
Diagnostic Assays: Used in biomarker detection for early cancer diagnosis.
Cell Adhesion Studies: Investigate the role of the protein in tumor progression and metastasis.
Tumor Biology Research: Helps in understanding the molecular pathways associated with tumor growth and immune evasion.
Drug Development: Supports the creation of novel therapeutics targeting CEACAM5.
Couldn't Find the Peptide You Need?
No problem! We will make it for you! For inquiries or custom peptide synthesis, contact us today!